Xolair 150 MG/ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTDV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,485
Award facts
- Contract value 100% obligated
- $10,484.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,484.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml. The delivery order, issued on November 25, 2025, with an ultimate completion date of December 11, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under DMS Pharmaceutical Group's recently established single-award Indefinite Delivery Contract (IDC) with the DLA, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
The PPV-G GEN V contract, awarded on November 13, 2025, represents a $30.3 billion acquisition strategy with DMS Pharmaceutical Group positioned as a regional prime vendor contractor with a ceiling value of $499,999,999 through December 31, 2036. Under this master contract structure, the DLA is authorized to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system with no identified subcontractor relationships.
Quick answers
Who was awarded contract SPE2DR26FBTDV?
SPE2DR26FBTDV was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FBTDV worth?
The government has obligated $10,485 on SPE2DR26FBTDV.
Is contract SPE2DR26FBTDV an order under another contract?
Yes. SPE2DR26FBTDV is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTDV competed?
The extent of competition for SPE2DR26FBTDV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award